Elanco Animal Health Inc (ELAN) reported better-than-expected financial results for the third quarter of fiscal 2025. The company's earnings per share (EPS) reached $0.19, surpassing Wall Street's consensus estimate of $0.13 by $0.06. Revenue matched expectations at $1.1 billion.
This update provides insight into Elanco's operational performance and financial health. The firm, headquartered in Greenfield, Indiana, develops and markets products for both pets and farm animals, employing approximately 9,000 people. Its diverse product portfolio includes around 200 brands, serving a global customer base across more than 90 countries.
Elanco will host its earnings conference call at BMO to discuss these results and provide further commentary on its business performance. The upcoming earnings report is scheduled for August 4, 2026, with an EPS estimate of $0.3021 and revenue expectations of $1.3 billion.
Investors should review the full earnings release and listen to management commentary for complete context on the quarter's performance and future outlook.